| Entry |
|
|---|
| Name |
6-Aminohexanoate;
6-Aminohexanoic acid;
Epsilcapramine;
6-Aminocaproic acid
|
|---|
| Formula |
C6H13NO2
|
|---|
| Exact mass |
131.0946
|
|---|
| Mol weight |
131.17
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map01120 | Microbial metabolism in diverse environments |
|
|---|
| Enzyme |
|
|---|
| Brite |
Lipids [BR:br08002]
FA Fatty acyls
FA01 Fatty Acids and Conjugates
FA0110 Amino fatty acids
C02378 6-Aminohexanoic acid
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02A ANTIFIBRINOLYTICS
B02AA Amino acids
B02AA01 Aminocaproic acid
D00160 Aminocaproic acid (USP/INN) <US>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Hemostasis Agents
Aminocaproic Acid
D00160 Aminocaproic acid (USP/INN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for ophthalmologic use
62 General eye drops
D00160 Aminocaproic acid (USP/INN)
67 Eyewash
D00160 Aminocaproic acid (USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
Epsilon-Aminocaproic acid
D00160 Aminocaproic acid (USP/INN)
Drug groups [BR:br08330]
Blood modifier agent
DG02016 Hemostatics
DG02012 Antifibrinolytic
DG01540 Plasmin inhibitor
D00160 Aminocaproic acid
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Serine peptidases
Chymotrypsin family
PLG
D00160 Aminocaproic acid (USP/INN) <US>
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 9
1 C1b C 21.8300 -17.6973
2 C1b C 23.0454 -18.3901
3 C1b C 20.6147 -18.3960
4 C6a C 24.2549 -17.6855
5 C1b C 19.4054 -17.7032
6 O6a O 25.4702 -18.3843
7 O6a O 24.2549 -16.2824
8 C1b C 18.1900 -18.4018
9 N1a N 16.9747 -17.7090
BOND 8
1 1 2 1
2 1 3 1
3 2 4 1
4 3 5 1
5 4 6 1
6 4 7 2
7 5 8 1
8 8 9 1
|
|---|
